Australia's largest stock trading and investment forum Australia's #1 stock forum

RAP

0.00%

20.5¢ raptor resources limited

Board members - Its time to buy or go, page-170

Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #

First 170 Last

Share
Profile

Follow
AlCp

27,388 Posts.

1778

08/03/21

13:38

Post #: 51599410
Share

Originally posted by Yenom23 ↑

Everyone seems to be hanging their hat in the success of medgate. I mean if people don’t realise, Medgate is just trying to make their service look more comprehensive with wider offerings. They will ‘trial’ with almost anyone to achieve this. That wa s the same with coviu and pheonix. The aim for Telehealth players to to ‘appear’ to be a one stop shop and make them as relevant as possible. It’s a ‘No Risk’ play for Medigate to trial Resapp and not be bound to anything going forward. I think that’s why they do it, just for people to perceive they have so many options online in terms of functionality, but in the end the doctors will have to want to use it...

Also, RAP will have probably 2-4 more announcements aimed at hyping up the shareprice before they pull the trigger on the cap raise. Be aware if it doesn’t work getting the price up, those buyers will be disappointed and likely turn around and sell.
It looks like morgans will lead this raise. Its a high risk strategy for their clients... I really can’t see many taking up the next raise - I’m guessing it will be spread around to other broking networks and RAP will have to give out some options (at least to the lead manager) to get it away.

Expand

No, Medgate are well advanced in the telehealth market with 20 years experience, they know they can now break into the massive respiratory consultation market which could only be done in clinic.

RAP Price at posting: 5.5¢ Sentiment: Buy Disclosure: Held
3 Upvote

0 Great analysis

Reply

Top Stories

CKA

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

BUX

Buxton projects new graphite province discovery at WA Narryer play

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

SLS

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

NTI

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

BCI

BCI reaches close of funding facility for salt-first part of Mardie project

WCN

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

There are more pages in this discussion • 3 more messages in this thread...

First 170 Last

Add RAP (ASX) to my watchlist

Board members - Its time to buy or go, page-170

Top Stories

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Buxton projects new graphite province discovery at WA Narryer play

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

BCI reaches close of funding facility for salt-first part of Mardie project

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Featured News